Kayne Anderson Rudnick Investment Management’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
HL
Kayne Anderson Rudnick Investment Management's GMAB Position: Q1 2024 in Review
Kayne Anderson Rudnick Investment Management sold out of Genmab (GMAB) in Q1 2024, closing a stake of 97,218 shares — an estimated $3.1M sold.
Kayne Anderson Rudnick Investment Management first reported a position in GMAB in Q3 2019 and held it in 18 quarters. The position peaked at $6.29M in Q3 2021. 228 funds tracked by Wall St. Rank hold GMAB as of Q1 2024.
- Kayne Anderson Rudnick Investment Management reported no remaining Genmab position as of Q1 2024 after selling out during the quarter.
- Kayne Anderson Rudnick Investment Management sold 97,218 Genmab shares in Q1 2024, an estimated $3.1M.
- Kayne Anderson Rudnick Investment Management first reported a position in Genmab in Q3 2019 and held it in 18 quarters.
- Kayne Anderson Rudnick Investment Management's Genmab position peaked at $6.29M in Q3 2021.
- 228 funds tracked by Wall St. Rank held Genmab as of Q1 2024.
Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2024, filed 14 May 2024.